Karen A. Dawes, Director at REPLIGEN CORP (RGEN), sold 1,520 shares at $202.23 ($307K) on 2021-07-13, disclosed to the SEC on 2021-07-15.
Scheduled sale ($307k) by Director.
Nothing distinguishes this filing.
| Filing → |
| RGEN | SELL | 2023-08-30 | $146K | — | Filing → |
| RGEN | SELL | 2022-09-09 | $352K | — | Filing → |
| RGEN | SELL | 2022-05-26 | $4.4M | — | Filing → |